NKTX
Nkarta Inc

2,167
Loading...
Loading...
Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
157

Frequently Asked Questions

What is Market Cap of Nkarta Inc?
What is the 52-week high for Nkarta Inc?
What is the 52-week low for Nkarta Inc?
What is Nkarta Inc stock price today?
What was Nkarta Inc stock price yesterday?
What is the PE ratio of Nkarta Inc?
What is the Price-to-Book ratio of Nkarta Inc?
What is the 50-day moving average of Nkarta Inc?
How many employess does Nkarta Inc has?

Latest NKTX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.